أ.د./ أمال محمد الجيار
|
|
Amal Mohammad El Gayar
Professor of Biochemistry
عنوان البريد الإلكتروني هذا محمي من روبوتات السبام. يجب عليك تفعيل الجافاسكربت لرؤيته.
|
| Research interest: |
Biochemistry, Molecular biology, Liver diseases, Diabetes, Hepatocellular carcinoma and oxidative stress.
|
|
Selected Publications: |
Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma. Eisa NH, Ebrahim MA, Ragab M, Eissa LA, El-Gayar AM. J Oncol Pharm Pract, 2014.
Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.Tayel A, Abd El Galil KH, Ebrahim MA, Ibrahim AS, El-Gayar AM, Al-Gayyar MM. Eur J Pharmacol. 2014, 728:151-60.
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model. Sahar A. Helmy, Mohamed El-Mesery, Amro El-Karef, Laila A.Eissa, Amal M. El Gayar Chemico-Biological Interactions (2018) 279:84-94.
|
